RETRACTED: Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer

Ali El-Far, Kavitha Godugu, Taher Salaheldin, Noureldien Darwish, Amna Saddiq, Shaker Mousa

Open source

DOI
10.3390/biomedicines9080990
Published
2021-08-10
Container
Biomedicines
Publisher
MDPI AG
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines9080990,
  title = {RETRACTED: Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer},
  author = {Ali El-Far and Kavitha Godugu and Taher Salaheldin and Noureldien Darwish and Amna Saddiq and Shaker Mousa},
  year = {2021},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines9080990},
  url = {https://doi.org/10.3390/biomedicines9080990}
}

RIS

TY  - JOUR
TI  - RETRACTED: Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer
AU  - Ali El-Far
AU  - Kavitha Godugu
AU  - Taher Salaheldin
AU  - Noureldien Darwish
AU  - Amna Saddiq
AU  - Shaker Mousa
PY  - 2021
JO  - Biomedicines
DO  - 10.3390/biomedicines9080990
UR  - https://doi.org/10.3390/biomedicines9080990
ER  - 

APA

El-Far, A., Godugu, K., Salaheldin, T., Darwish, N., Saddiq, A., & Mousa, S. (2021). RETRACTED: Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer. Biomedicines. https://doi.org/10.3390/biomedicines9080990

Source records